当前位置:
X-MOL 学术
›
Obstet. Gynecol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Complete Response to Combination Nivolumab and Ipilimumab in Recurrent Neuroendocrine Carcinoma of the Cervix.
Obstetrics and Gynecology ( IF 7.2 ) Pub Date : 2021-10-07 , DOI: 10.1097/aog.0000000000004573 Thomas A Paterniti 1 , Katie Dorr , Asad Ullah , Joseph White , Hadyn Williams , Sharad Ghamande
Obstetrics and Gynecology ( IF 7.2 ) Pub Date : 2021-10-07 , DOI: 10.1097/aog.0000000000004573 Thomas A Paterniti 1 , Katie Dorr , Asad Ullah , Joseph White , Hadyn Williams , Sharad Ghamande
Affiliation
Small cell neuroendocrine carcinoma of the cervix is a rare, aggressive tumor treated with a combination of surgery, chemotherapy, and radiation. Survival rates are poor, and innovative therapies are needed.
中文翻译:
纳武单抗和伊匹单抗联合治疗复发性宫颈神经内分泌癌的完全缓解。
宫颈小细胞神经内分泌癌是一种罕见的侵袭性肿瘤,可通过手术、化疗和放疗联合治疗。存活率很低,需要创新疗法。
更新日期:2021-10-07
中文翻译:
纳武单抗和伊匹单抗联合治疗复发性宫颈神经内分泌癌的完全缓解。
宫颈小细胞神经内分泌癌是一种罕见的侵袭性肿瘤,可通过手术、化疗和放疗联合治疗。存活率很低,需要创新疗法。